These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2091826

  • 21. [Evaluation of antihypertensive therapy by ambulatory blood pressure monitoring and establishment of the level of antihypertensive goal on the circadian rhythm of blood pressure].
    Fujioka T, Tamaki S, Fudo T, Nakae I, Sugawara A, Kambara H.
    Kokyu To Junkan; 1990 Jan; 38(1):71-6. PubMed ID: 2305128
    [Abstract] [Full Text] [Related]

  • 22. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Clerson P.
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [Abstract] [Full Text] [Related]

  • 23. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 24. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M, Morillo J, Urbina A, Kögler P, Leishman B, Pasquier M, Hernändez-Pieretti O.
    Int J Clin Pharmacol Res; 1987 Mar; 7(6):443-54. PubMed ID: 3440635
    [Abstract] [Full Text] [Related]

  • 26. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J.
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of nitrendipine in the treatment of elderly hypertensive subjects, and its effect on cerebral blood flow.
    Pandita-Gunawardena ND, Dorrance DE, MacDonald G.
    J Cardiovasc Pharmacol; 1989 Oct; 14 Suppl 10():S52-8. PubMed ID: 2483572
    [Abstract] [Full Text] [Related]

  • 28. [Efficacy and tolerance of a new calcium-channel blocking agent (nitrendipine) in the treatment of arterial hypertension].
    Lopes HF, Silva HB, Bellotti G, Pillegi F.
    Arq Bras Cardiol; 1990 Mar; 54(3):227-9. PubMed ID: 2288512
    [Abstract] [Full Text] [Related]

  • 29. [Study of the influence of the time of administration on the antihypertensive effect and nitrendipine tolerance in mild to moderate essential hypertensive patients. Value of ambulatory recording of blood pressure on 24 hours].
    Meilhac B, Mallion JM, Carre A, Chanudet X, Poggi L, Gosse P, Dallocchio M.
    Therapie; 1992 Mar; 47(3):205-10. PubMed ID: 1295122
    [Abstract] [Full Text] [Related]

  • 30. 24-hour noninvasive oscillometric blood pressure monitoring: evaluation of the antihypertensive circadian profile of nitrendipine.
    Meyer-Sabellek W, Schulte KL, Streitberg B, Gotzen R, Distler A.
    J Cardiovasc Pharmacol; 1988 Mar; 12 Suppl 4():S22-8. PubMed ID: 2468870
    [Abstract] [Full Text] [Related]

  • 31. Benazepril at incremental doses in essential hypertension.
    Fogari R, Tettamanti F, Poletti L, Malamani G, Sardina M, Savonitto S.
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):63-6. PubMed ID: 2407670
    [Abstract] [Full Text] [Related]

  • 32. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA, Drayer JI.
    J Cardiovasc Pharmacol; 1984 Feb; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [Abstract] [Full Text] [Related]

  • 33. Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.
    Wang X, Gong L, Guo J, Wang X, Liu Y, Ye X, Zhang G, Yang P.
    J Hypertens Suppl; 1998 Sep; 16(4):S43-7. PubMed ID: 9817192
    [Abstract] [Full Text] [Related]

  • 34. Saluretic and diuretic effects of antihypertensive nitrendipine monotherapy in man.
    Sambhi MP.
    Angiology; 1988 Jan; 39(1 Pt 2):106-12. PubMed ID: 3341609
    [Abstract] [Full Text] [Related]

  • 35. [Nitrendipine in the treatment of mild-moderate essential arterial hypertension. Ambulatory study in Primary Care].
    Calvo Gómez C, Lado Lado F, Gude Sampedro F, Cinos Ramos L.
    An Med Interna; 1993 Jul; 10(7):333-6. PubMed ID: 8218766
    [Abstract] [Full Text] [Related]

  • 36. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg AI, Nelson EB.
    Arch Intern Med; 1995 Feb 27; 155(4):405-11. PubMed ID: 7848024
    [Abstract] [Full Text] [Related]

  • 37. [Sustained-released verapamil and ambulatory recording of blood pressure in mild to moderate essential hypertension].
    Bernadet P, Suc JM, Durand D, Galey C, Maarek-Charbit M.
    Ann Cardiol Angeiol (Paris); 1992 Feb 27; 41(2):105-12. PubMed ID: 1562157
    [Abstract] [Full Text] [Related]

  • 38. Amiloride compared with nitrendipine in treatment of essential hypertension.
    Katzman PL, Henningsen NC, Hulthén UL.
    J Hum Hypertens; 1988 Oct 27; 2(3):147-51. PubMed ID: 3236318
    [Abstract] [Full Text] [Related]

  • 39. [Blood pressure response to antihypertension treatment. Comparison of data obtained at the doctor's office and by ambulatory blood pressure measurement].
    Herpin D, Degand B, Raynier P, Guyon C, Amiel A, Boutaud P, Demange J.
    Arch Mal Coeur Vaiss; 1989 Oct 27; 82(10):1733-7. PubMed ID: 2512875
    [Abstract] [Full Text] [Related]

  • 40. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep 27; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.